FDA Inspection 1133868 — Lonza Houston, Inc
The FDA completed an inspection of Lonza Houston, Inc on December 10, 2020 in Houston, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 10, 2020
- Fiscal Year
- 2021
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Houston, TX (United States)